Search Results - "Zelenkofske, S L"

Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System to Clinical Trial Design by Povsic, T. J., Cohen, M. G., Chan, M. Y., Zelenkofske, S. L., Wargin, W. A., Harrington, R. A., Alexander, J. H., Rusconi, C. P., Becker, R. C.

“…We performed detailed pharmacokinetic and pharmacodynamic modeling of REG1, an anticoagulation system composed of the direct factor IXa (FIXa) inhibitor…”
Get full text

The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty by McGarry, Jr, T F, Gottlieb, R S, Morganroth, J, Zelenkofske, S L, Kasparian, H, Duca, P R, Lester, R M, Kreulen, T H

“…The degree of anticoagulation and its effect on the frequency of abrupt coronary artery closure, coronary ischemia, bleeding complications requiring…”
Get more information

Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy by Povsic, Thomas J., Wargin, William A., Alexander, John H., Krasnow, Joshua, Krolick, Merill, Cohen, Mauricio G., Mehran, Roxana, Buller, Christopher E., Bode, Christoph, Zelenkofske, Steven L., Rusconi, Christopher P., Becker, Richard C.

“…Aims Establishing factor IX inhibition in patients with acute coronary syndrome/non-ST-elevation myocardial infarction (ACS/NSTEMI), a setting characterized by…”
Get full text

Time-limited efficacy of pacing electrodes following open heart surgery by Kosmas, C E, Ryder, R G, Poon, M J, Zelenkofske, S L, Banka, V S

“…Temporary epicardial pacing electrodes have been utilised since the 1960s in the postoperative management of cardiac surgical patients, both as a diagnostic…”
Get full text